Can You Get Mounjaro on the NHS?

Medically reviewed by Puja Vyas, Lead Clinical Pharmacist.

‍

Yes, you can get Mounjaro on the NHS in England, but the eligibility criteria are significantly more restrictive than private prescribing, and most women who want it will not currently qualify through their GP.

NHS England is gradually phasing in access to Mounjaro. As of October 2026, two cohorts are active: one for people with a BMI of 40 or above, and one for BMI 35 to 39.9. Both require at least four of five specific health conditions alongside the BMI threshold.

If you do not meet those criteria, or are not willing to wait, you can opt for private prescribing, which is available with a lower BMI threshold and a much shorter wait.

Key Takeaways

• Mounjaro is available on the NHS in England, but access is strictly phased, and criteria are more restrictive than NICE's full clinical recommendation
• Cohort 1 (BMI 40+, 4 of 5 conditions) has been available via GP since June 2025. Cohort 2 (BMI 35 to 39.9, 4 of 5 conditions) went live on 23 June 2026
• The five qualifying conditions are type 2 diabetes, hypertension, dyslipidaemia (high cholesterol or triglycerides), obstructive sleep apnoea, and cardiovascular disease
• NHS Tier 3 specialist weight management services have waiting times of 12 to 36 months in most areas
• Private prescribing is available from BMI 30 (or 27.5 with one comorbidity) with no waiting list
• BMI thresholds are 2.5 points lower for South Asian, Chinese, other Asian, Middle Eastern, Black African, and African-Caribbean backgrounds at every NHS cohort level

NHS Eligibility Criteria for Mounjaro

NICE (the National Institute for Health and Care Excellence), an independent public organisation that sets rules and advises the NHS on treatments and medicines, recommended Mounjaro for adults with a BMI of at least 35 and at least one weight-related health condition, based on its technology appraisal published in December 2024.

With that, NHS England estimated that up to 2.8 million people could meet the full NICE criteria. Hence, they are rolling out the medicine in phases to manage capacity. This means NHS England's active prescribing criteria are currently more restrictive than NICE's underlying recommendation.

The Current NHS Cohorts (October 2026)

‍

‍

The Five Qualifying Health Conditions

For both Cohort 1 and Cohort 2, you need at least four of the following five conditions alongside your BMI:

• Type 2 diabetes
• Hypertension (high blood pressure)
• Dyslipidaemia (high cholesterol or elevated triglycerides)
• Obstructive sleep apnoea
• Cardiovascular disease (including previous heart attack or stroke)

Obesity, irrespective of BMI, will not qualify you for NHS primary care Mounjaro currently under Cohorts 1 or 2. You’ll need the BMI threshold plus at least four of the five conditions above.

How This Differs From Private Eligibility

In the case of private prescribers, the criteria are much more lenient: a BMI of 30 or above, or a BMI of 27.5 or above with at least one weight-related health condition. This is why many women who would clinically benefit from Mounjaro do not qualify for it on the NHS.

On the criteria gap: this is one of the more frustrating parts of the current NHS landscape. NICE reviewed the evidence and said Mounjaro should be available from BMI 35 with one condition. NHS England said yes, but we need to phase it because we cannot prescribe to millions of people overnight. That is a genuine capacity argument, not a safety or clinical one. What it means in practice is that a woman with a BMI of 33 and hypertension meets NICE’s clinical criteria but does not currently meet NHS commissioning criteria. Those are two different things, and it is worth understanding the difference.

How the NHS Rollout Is Being Phased

Current Waiting Times and Regional Variation

For the two active cohorts, access comes through your GP. Book an appointment, explain that you want to discuss Mounjaro for weight management, and ask whether your practice is currently prescribing it. Not every GP surgery has set this up yet, so it is worth asking directly rather than assuming. If your practice is prescribing it, the process from that appointment to a prescription can take days to a few weeks depending on how busy your surgery and local NHS area is.

For the two cohorts that are currently active, your GP would be your source for the NHS primary care pathway. You’d have to book an appointment, explain that you want to discuss Mounjaro for weight management, and ask whether your practice is currently prescribing it. Not every GP surgery has this set up yet, so it’s better you ask before you go.

Even if they do, the waiting time for these services can be frustrating, as it typically ranges between 3 and 12 months in most areas. London, Birmingham, and other urban areas experience the longest waits.

When the next Cohort will begin

NHS England has indicated 2027/28 for Cohort 3. This will include adults with a BMI of 40 or above and at least three qualifying conditions (reduced from four). There is a plan to further extend the cohorts to the NICE-recommended BMI 35 with one condition, but the timeline for full rollout extends over several years.

This is a fast-moving area. Criteria, cohorts, and timelines have changed and continue to change. The dates in this article reflect the position as of October 2026. Check current NHS England guidance before making any decisions based on eligibility.

How to Check If You Qualify for NHS Mounjaro

Take your GP’s help to -

• Check your current BMI against the active cohort thresholds (40+ for Cohort 1, 35 to 39.9 for Cohort 2, with adjustments for some ethnic backgrounds)
• Identify whether you have at least four of the five qualifying conditions confirmed in your medical records: type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease
• Check your local NHS website or GP practice website for official updates on whether Mounjaro is available in your area. 
• If not, ask about a Tier 3 referral or whether a neighbouring practice within your ICB is prescribing

‍

Important note: If you meet the NHS criteria and it is being prescribed locally, eligible patients are typically contacted directly rather than needing to book a separate appointment to ask. Calling or visiting your practice specifically to ask about Mounjaro is creating backlogs in some areas. This is why checking online first is the more considerate and often faster route. 

‍

What Happens If You Don’t Currently Meet NHS Criteria

If your BMI is below 35, or you have fewer than four of the five qualifying conditions, you do not currently qualify for NHS primary care Mounjaro under the active cohorts. In this case, you can explore Tier 3 specialist weight management services. They operate under slightly different criteria, but you’ll have to be ready to wait for 12 to 36 months.

Or you could consider private prescribing, which is available now at lower thresholds and without a waiting list.

Here’s an article if you want to know more about Mounjaro’s safety: Is Mounjaro safe? What we need to know →

‍

How Private Prescribing Compares

‍

‍

When you opt for private prescribing, you’re not just opting for a faster prescription, but rather support that your body needed all this while, but was being denied due to logistical reasons.

What Ongoing Support Looks Like

The NHS route typically involves a prescription and standard GP monitoring, but the level of structured clinical support varies significantly by practice. Some ICBs provide structured support; others do not.

At SheMed, we include a free at-home blood test before starting, covering thyroid function, HbA1c, fasting glucose, cholesterol, and liver enzymes before every prescription. Our clinicians check in at dose escalation points, and we also provide app-based tracking. This is because we are not in the business of selling medicines. We are on a mission to improve the lives of women and provide them the care that they very much deserve.  

Our aim here is not to tell you that NHS care is inferior, but to inform you about what the two pathways typically include in practice.

An honest way to think about this: if you meet the NHS criteria and can wait, the NHS route is free and clinically appropriate. If you do not meet the current NHS criteria but do meet private criteria, or if waiting 12 to 36 months for a Tier 3 appointment is not realistic for you, private prescribing is a legitimate option.

Neither path is wrong. The question is what fits your situation. And if your situation changes, either because NHS criteria expand or your own circumstances shift, so can your approach.

If you meet private criteria and don’t want to wait: SheMed’s Mounjaro programme includes a full clinical assessment and blood test before anything is prescribed.

Clinician-led. No waiting list. See the Mounjaro product→

Frequently Asked Questions

What is the NHS criteria for Mounjaro?

As of October 2026, NHS primary care prescribing covers two cohorts. Cohort 1 requires a BMI of 40 or above (37.5 for some ethnic groups) plus at least four of the five qualifying conditions: type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea, and cardiovascular disease. Cohort 2, live from 23 June 2026, covers BMI 35 to 39.9 (32.5 to 37.4 for some ethnic groups) with the same four-condition requirement.

Is Mounjaro free on the NHS?

Yes, for those who qualify. If you meet the current NHS primary care cohort criteria, Mounjaro is prescribed on an NHS prescription at the standard prescription charge (or free for those who are exempt, which includes everyone in Wales, Scotland, and Northern Ireland, as well as those with a qualifying condition or prepayment certificate in England).

How long is the NHS waiting list for Mounjaro?

For the active primary care cohorts (Cohort 1 and Cohort 2), access comes through your GP, and the wait depends on your practice and ICB. Some practices can prescribe within days of a GP appointment. For Tier 3 specialist weight management services, which serve patients who do not meet the primary care cohort criteria, waiting times are typically 12 to 36 months depending on your area.

Can I get Mounjaro on the NHS for weight loss, or only for diabetes?

Both. Mounjaro is available on the NHS for weight management (under the phased primary care rollout) and for type 2 diabetes (under a separate NICE recommendation). Both conditions have different eligibility criteria. The weight management route currently requires the BMI and four-condition thresholds described above. The type 2 diabetes route has its own clinical criteria, which your GP can assess.

‍

Sources and Further Reading

1. NICE – TA1026: Tirzepatide (Mounjaro) for Managing Overweight and Obesity (December 2024)

2. NHS England – Commissioning Guidance: Mounjaro (Tirzepatide) in Primary Care (April 2026)

3. House of Commons Library – Weight Loss Medicines in England: GLP-1 Rollout Analysis

4. MHRA – Mounjaro (Tirzepatide) Regulatory Approval for Weight Management

5. SheMed – Is Mounjaro Safe? What We Need to Know

6. SheMed – Mounjaro Dosage Guide: Doses, Injection Sites and Pricing

‍

‍